Menu
Back to User profile » Professor Shaker A Mousa
Papers published by Professor Shaker A Mousa:
Chitosan-Based Nanoformulated (–)-Epigallocatechin-3-Gallate (EGCG) Modulates Human Keratinocyte-Induced Responses and Alleviates Imiquimod-Induced Murine Psoriasiform Dermatitis [Erratum]
Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H
International Journal of Nanomedicine 2023, 18:2503-2505
Published Date: 11 May 2023
Evaluation of Natural Bioactive-Derived Punicalagin Niosomes in Skin-Aging Processes Accelerated by Oxidant and Ultraviolet Radiation [Retraction]
Mohamad EA, Aly AA, Khalaf AA, Ahmed MI, Kamel RM, Abdelnaby SM, Abdelzaher YH, Sedrak MG, Mousa SA
Drug Design, Development and Therapy 2023, 17:807-808
Published Date: 13 March 2023
IR-Enhanced Photothermal Therapeutic Effect of Graphene Magnetite Nanocomposite on Human Liver Cancer HepG2 Cell Model [Retraction]
Salaheldin TA, Loutfy SA, Ramadan MA, Youssef T, Mousa SA
International Journal of Nanomedicine 2022, 17:4723-4724
Published Date: 6 October 2022
Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation [Retraction]
Mousa DS, El-Far AH, Saddiq AA, Sudha T, Mousa SA
International Journal of Nanomedicine 2022, 17:3579-3580
Published Date: 11 August 2022
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Retraction]
Loutfy SA, Elberry MH, Farroh KY, Mohamed HT, Mohamed AA, Mohamed EB, Faraag AHI, Mousa SA
International Journal of Nanomedicine 2022, 17:2891-2892
Published Date: 5 July 2022
Activation of Polymeric Nanoparticle Intracellular Targeting Overcomes Chemodrug Resistance in Human Primary Patient Breast Cancer Cells [Retraction]
Abou-El-Naga AM, Mutawa G, El-Sherbiny IM, Mousa SA
International Journal of Nanomedicine 2022, 17:2555-2556
Published Date: 3 June 2022
Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
Al-Gabri NA, Saghir SAM, Al-Hashedi SA, El-Far AH, Khafaga AF, Swelum AA, Al-wajeeh AS, Mousa SA, Abd El-Hack ME, Naiel MAE, El-Tarabily KA
International Journal of Nanomedicine 2021, 16:5117-5131
Published Date: 27 July 2021
RETRACTED ARTICLE: Evaluation of Natural Bioactive-Derived Punicalagin Niosomes in Skin-Aging Processes Accelerated by Oxidant and Ultraviolet Radiation
Mohamad EA, Aly AA, Khalaf AA, Ahmed MI, Kamel RM, Abdelnaby SM, Abdelzaher YH, Sedrak MG, Mousa SA
Drug Design, Development and Therapy 2021, 15:3151-3162
Published Date: 17 July 2021
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]
Loutfy SA, Elberry MH, Farroh KY, Mohamed HT, Mohamed AA, Mohamed EB, Faraag AHI, Mousa SA
International Journal of Nanomedicine 2021, 16:1927-1928
Published Date: 5 March 2021
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines
Loutfy SA, Elberry MH, Farroh KY, Mohamed HT, Mohamed AA, Mohamed EB, Faraag AHI, Mousa SA
International Journal of Nanomedicine 2020, 15:2699-2715
Published Date: 22 April 2020
Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation
Mousa DS, El-Far AH, Saddiq AA, Sudha T, Mousa SA
International Journal of Nanomedicine 2020, 15:2259-2268
Published Date: 31 March 2020
Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release
Shahein SA, Aboul-Enein AM, Higazy IM, Abou-Elella F, Lojkowski W, Ahmed ER, Mousa SA, AbouAitah K
International Journal of Nanomedicine 2019, 14:5503-5526
Published Date: 19 July 2019
RETRACTED ARTICLE: IR-enhanced photothermal therapeutic effect of graphene magnetite nanocomposite on human liver cancer HepG2 cell model
Salaheldin TA, Loutfy SA, Ramadan MA, Youssef T, Mousa SA
International Journal of Nanomedicine 2019, 14:4397-4412
Published Date: 17 June 2019
Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells
Abou-El-Naga AM, Mutawa G, El-Sherbiny IM, Mousa SA
International Journal of Nanomedicine 2018, 13:8153-8164
Published Date: 29 November 2018
Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H
International Journal of Nanomedicine 2018, 13:4189-4206
Published Date: 20 July 2018
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
Sudha T, Bharali DJ, Yalcin M, Darwish NHE, Debreli Coskun M, Keating KA, Lin HY, Davis PJ, Mousa SA
International Journal of Nanomedicine 2017, 12:1305-1315
Published Date: 15 February 2017
Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention
Shirode AB, Bharali DJ, Nallanthighal S, Coon JK, Mousa SA, Reliene R
International Journal of Nanomedicine 2015, 10:475-484
Published Date: 9 January 2015
Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis
Davis PJ, Lin HY, Sudha T, Yalcin M, Tang HY, Hercbergs A, Leith JT, Luidens MK, Ashur-Fabian O, Incerpi S, Mousa SA
OncoTargets and Therapy 2014, 7:1619-1624
Published Date: 18 September 2014
Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
Thomas M, Mousa SS, Mousa SA
Clinical Ophthalmology 2013, 7:495-501
Published Date: 8 March 2013
Current primary open-angle glaucoma treatments and future directions
Beidoe G, Mousa SA
Clinical Ophthalmology 2012, 6:1699-1707
Published Date: 23 October 2012
Biosensors: the new wave in cancer diagnosis
Brian Bohunicky, Shaker A Mousa
Nanotechnology, Science and Applications 2011, 4:1-10
Published Date: 30 December 2010
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Whitney P Caron, Shaker A Mousa
Infection and Drug Resistance 2010, 3:25-33
Published Date: 21 May 2010
Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
Yun Lin, Shaymaa S Mousa, Nabil Elshourbagy, et al
Vascular Health and Risk Management 2010, 6:73-85
Published Date: 12 February 2010